The large database of information contained in the California Cancer Registry is useful for both local clinicians and researchers around the world, as it allows them to compare cancer outcomes by a number of demographic characteristics, according to Moon S. Chen Jr, PhD, MPH, professor of hematology and oncology at UC Davis Comprehensive Cancer Center and principal investigator of The National Center for Reducing Asian American Cancer Health Disparities.
The large database of information contained in the California Cancer Registry is useful for both local clinicians and researchers around the world, as it allows them to compare cancer outcomes by a number of demographic characteristics, according to Moon S. Chen Jr, PhD, MPH, professor of hematology and oncology at UC Davis Comprehensive Cancer Center and principal investigator of The National Center for Reducing Asian American Cancer Health Disparities.
Transcript (slightly modified)
Why is it important to gather epidemiology data in efforts like the California Cancer Registry?
We in California have been extremely fortunate to have had the California Cancer Registry. This is the oldest, largest cancer registry in the world in a contiguous area. The data have been collected for more than 25 years, and we, by legislation, track all cancer cases and we’re able to collect information on the first course of treatment, what happens to the patient, the kinds of survival outcomes that have occurred.
That has helped the individual provider by saying, I can go to the California Cancer Registry and see how people of the patients that I’m dealing with, by gender, by race, and so forth, even by geography in part of California: how have they done? What has been used before? Then compare my patient load to that situation and see what can be learned and what can be applied, what has worked and how does what I’m doing compare with what has been done in the past. I think that’s the major advantage of the California Cancer Registry to the individual.
To the nation at large or the world at large, it’s the opportunity to have so much diversity in terms of race, ethnicity, and so forth, to be able to see the potential outcomes and course for all these groups.
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
March 13th 2025The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Addressing Financial Aid and Patient Independence as Part of Atopic Dermatitis Care
March 13th 2025Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition were emphasized at this year’s 2025 American Academy of Dermatology meeting.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir
March 13th 2025The combination of doravirine plus islatravir was noninferior to bictegravir/emtricitabine/tenofovir alafenamide and oral antiretroviral therapy in patients who switched to doravirine plus islatravir.
Read More